CLINICAL PROFILE OF TUBERCULOSIS PATIENTS (PULMONARY AND EXTRA-PULMONARY) PRESENTING TO A TERTIARY CARE HOSPITAL

Amit Satish Gupta, Aditya Airan, Apurva Satish Gupta
{"title":"CLINICAL PROFILE OF TUBERCULOSIS PATIENTS (PULMONARY AND EXTRA-PULMONARY) PRESENTING TO A TERTIARY CARE HOSPITAL","authors":"Amit Satish Gupta, Aditya Airan, Apurva Satish Gupta","doi":"10.22159/ajpcr.2024.v17i6.51524","DOIUrl":null,"url":null,"abstract":"Objective: The objective of the study is to estimate the burden of tuberculosis (TB) patients, both pulmonary and extra-pulmonary, presenting to a tertiary care hospital in southern Rajasthan and to understand the resistance pattern among them.\nMethods: It is a retrospective observational study. The duration of the study was 3 years (January 2021–December 2023). Data were collected from TB registers maintained by the respiratory medicine department. The inclusion criteria were all suspected TB patients (pulmonary and extra-pulmonary). Both microbiologically confirmed and clinically diagnosed TB patients were included in the study.\nResults: The total number of sputum samples received of suspected pulmonary TB patients was 1923, out of which 600 (31.2%) were acid–fast bacilli (AFB) smear positive. The total number of samples received for CBNAAT testing was 1292, out of which 266 (20.59%) were CBNAAT positive. Total multidrug-resistant (MDR) TB patients were 58 (49 pulmonary TB and 9 extra-pulmonary TB (EPTB) [5 lymph, 3 pleural, and 1 bone]). The percentage of MDR-pulmonary TB patients among total sputum samples tested was 2.55%. The total number of pulmonary TB patients diagnosed was 1016 (microbiologically confirmed 866 + clinically diagnosed 150). Total EPTB patients diagnosed were 805 (microbiologically confirmed 141 + clinically diagnosed 664).\nConclusion: 31.2% of total sputum samples tested of suspected pulmonary TB patients were AFB smear positive, and 20.59% were CBNAAT positive. Most of the patients diagnosed with EPTB were diagnosed on a clincoradiological basis. The percentage of MDR–PTB among all sputum samples tested was 2.55%.","PeriodicalId":8528,"journal":{"name":"Asian Journal of Pharmaceutical and Clinical Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutical and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22159/ajpcr.2024.v17i6.51524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The objective of the study is to estimate the burden of tuberculosis (TB) patients, both pulmonary and extra-pulmonary, presenting to a tertiary care hospital in southern Rajasthan and to understand the resistance pattern among them. Methods: It is a retrospective observational study. The duration of the study was 3 years (January 2021–December 2023). Data were collected from TB registers maintained by the respiratory medicine department. The inclusion criteria were all suspected TB patients (pulmonary and extra-pulmonary). Both microbiologically confirmed and clinically diagnosed TB patients were included in the study. Results: The total number of sputum samples received of suspected pulmonary TB patients was 1923, out of which 600 (31.2%) were acid–fast bacilli (AFB) smear positive. The total number of samples received for CBNAAT testing was 1292, out of which 266 (20.59%) were CBNAAT positive. Total multidrug-resistant (MDR) TB patients were 58 (49 pulmonary TB and 9 extra-pulmonary TB (EPTB) [5 lymph, 3 pleural, and 1 bone]). The percentage of MDR-pulmonary TB patients among total sputum samples tested was 2.55%. The total number of pulmonary TB patients diagnosed was 1016 (microbiologically confirmed 866 + clinically diagnosed 150). Total EPTB patients diagnosed were 805 (microbiologically confirmed 141 + clinically diagnosed 664). Conclusion: 31.2% of total sputum samples tested of suspected pulmonary TB patients were AFB smear positive, and 20.59% were CBNAAT positive. Most of the patients diagnosed with EPTB were diagnosed on a clincoradiological basis. The percentage of MDR–PTB among all sputum samples tested was 2.55%.
在一家三级医院就诊的肺结核患者(肺部和肺外)的临床概况
研究目的本研究旨在估算在拉贾斯坦邦南部一家三级医院就诊的肺结核(TB)患者(包括肺内和肺外患者)的负担,并了解他们的耐药性模式:这是一项回顾性观察研究。研究为期 3 年(2021 年 1 月至 2023 年 12 月)。数据收集自呼吸内科的结核病登记簿。纳入标准为所有疑似肺结核患者(肺内和肺外)。经微生物学确诊和临床诊断的肺结核患者均被纳入研究范围:研究结果:共收到 1923 份肺结核疑似患者的痰液样本,其中 600 份(31.2%)为耐酸杆菌(AFB)涂片阳性。接受 CBNAAT 检测的样本总数为 1292 个,其中 266 个样本(20.59%)呈 CBNAAT 阳性。耐多药肺结核(MDR)患者总数为 58 例(49 例肺结核和 9 例肺外结核(EPTB)[5 例淋巴结核、3 例胸膜结核和 1 例骨结核])。经检测的痰样本中,MDR 肺结核患者占 2.55%。确诊的肺结核患者总数为 1016 人(微生物确诊 866 人 + 临床诊断 150 人)。结论:肺结核疑似患者的痰液样本中,AFB 涂片阳性者占 31.2%,CBNAAT 阳性者占 20.59%。大多数确诊为肺结核的患者都是通过临床放射学检查确诊的。在所有检测的痰样本中,耐多药肺结核的比例为 2.55%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信